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IntroductIon
Within the adult hematopoietic system, generation of various 
mature blood cell types is the result of several cell lineage 
choices and differentiation steps. At each particular branching 
or differentiation point, the silencing of genes from alterna-
tive lineages is crucial for acquiring the correct identity of 
the newly generated cell. In bone marrow, lymphoid-primed 
multipotent progenitors commit to the lymphoid branch by 
generating common lymphoid progenitors, which, in turn, 
have the ability to give rise to early B and T lymphocyte 
progenitors (Kondo et al., 1997; Cobaleda and Busslinger, 
2008). Once generated, B cell progenitors (pro–B cells) un-
dergo a series of differentiation steps that result in the gen-
eration of B cell precursors (pre–B cells) and immature B 
lymphocytes (Parra, 2009; Barneda-Zahonero et al., 2012). 
The latter migrate to the spleen to complete their matura-
tion (Parra, 2009; Barneda-Zahonero et al., 2012). Intense 
research effort has revealed the identity and role of specific 
transcription factors responsible for the activation of B cell–
specific genes (Parra, 2009; Barneda-Zahonero et al., 2012). 
The transcription factors E2A, EBF, and FOXO1 are involved 
in the early specification of common lymphoid progenitors 
into pro–B cells, whereas PAX5 is required to maintain B cell 
identity during differentiation into mature B cells (Urbánek 
et al., 1994; Zhuang et al., 1994; Lin and Grosschedl, 1995; 
Bain et al., 1997; Delogu et al., 2006; Dengler et al., 2008). 
Recently, Schwickert et al. (2014) reported that IKA ROS is 
also required for early B cell development. In all cases, tran-
scription factors induce the expression of genes characteristic 
of B cells. Notably, the transcription factor PAX5 not only 
induces the expression of a B cell–specific genetic program, 
but also suppresses inappropriate genes of alternative lineages, 
thereby ensuring proper B cell differentiation (Delogu et al., 
2006; Pridans et al., 2008). Likewise, EBF and E2A are also 
involved in the repression of non–B cell genes (Ikawa et al., 
2004; Pongubala et al., 2008; Lukin et al., 2011; Nechanitzky 
et al., 2013). The transcription factor myocyte enhancer fac-
tor 2C (MEF2C) is involved in the commitment of cells to 
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the lymphoid lineage by activating lymphoid-specific genes 
and repressing myeloid genes (Stehling-Sun et al., 2009; 
Kong et al., 2016). How B cell transcription factors induce 
the silencing of genes that should not be expressed in B cells 
remains largely unknown.
The large superfamily of histone or protein deacetyl-
ases (HDACs) are crucial transcriptional repressors in many 
physiological and pathological processes. Among them, the 
class IIa HDAC subfamily, comprising HDAC4, HDAC5, 
HDAC7, and HDAC9, has specific features that differ from 
all other HDACs, such as tissue specificity and interaction 
with transcription factors (Parra and Verdin, 2010; Parra, 
2015). Recently, we found that HDAC7 is down-regulated 
during the in vitro reprogramming of pre–B cells into mac-
rophages, whereas exogenous expression of HDAC7 inter-
fered with the acquisition of essential macrophage-specific 
cell functions in this in vitro system (Barneda-Zahonero et 
al., 2013). However, a role for HDAC7 in B cell develop-
ment in vivo remains to be established. Of interest, Lin et al. 
(2010) identified Hdac7 as a target of E2A, EBF, and Foxo1 
in B lymphocyte progenitors, whereas Revilla-i-Domingo et 
al. (2012) showed that Hdac7 may be a PAX5-activated gene. 
Whyte et al. (2013) showed that genes involved in cell lineage 
identity contain superenhancer regions that recruit specific 
transcription factors leading to their expression. Strikingly, 
they identified Hdac7 as one of the lineage identity genes 
bearing a superenhancer region in pro–B cells (Whyte et al., 
2013). These recent studies suggest that HDAC7 may regu-
late B cell development.
Here, we demonstrate that HDAC7 is essential for 
proper B cell development. Specifically, HDAC7 deficiency 
in pro–B cells in mice causes a block in early B cell develop-
ment. This is accompanied by expression of genes from alter-
native lineages, such as myeloid cells and T lymphocytes. We 
propose that HDAC7-mediated repression occurs through 
MEF2C recruitment to crucial myeloid and T cell genes. 
These findings establish HDAC7 as a bona fide transcriptional 
repressor necessary for the acquisition of the correct gene cell 
identity during B cell generation.
rEsults And dIscussIon
To investigate the potential role of HDAC7 in adult B 
lymphopoiesis, we generated a conditional mouse model for 
HDAC7 deficiency in pro–B cells. To this end, we crossed 
Hdac7loxp/− mice with the deleter line mb1-Cre, mb1-Creki/+ 
mice (Hobeika et al., 2006). An initial analysis of bone mar-
row and spleen revealed a 30% and 45% reduction, respec-
tively, in the total number of cells in Hdac7loxp/−;mb1-Creki/+ 
mice (referred to as Hdac7fl/−) compared with their lit-
termate controls Hdac7+/−;mb1-Creki/+ (Hdac7+/− mice; 
Fig. 1 A). Accordingly, we observed markedly smaller spleens 
in HDAC7 conditional knockout mice than in their litter-
mate controls (Fig. 1 B). A detailed flow cytometry analysis 
of the various B cell subsets in the bone marrow showed that 
HDAC7 deficiency causes a block in B cell development at 
the pro–B to pre–B cell transition. In particular, we observed 
a significant decrease in the total number of B cells and an ac-
cumulation of pro–B cells in Hdac7fl/− compared with their 
littermate controls, Hdac7+/− (Fig. 1 C, and see Fig. S1, A–C 
for gating strategy). In contrast, the number of pre–B cells 
was significantly lower while immature and mature recircu-
lating B cells were hardly detectable in the bone marrow of 
HDAC7 mutant mice (Fig.  1  C). Our staining strategy to 
distinguish between pro–B (B220+IgM−CD43+) and pre–B 
(B220+IgM−CD43−) lymphocytes revealed the presence of 
cells expressing intermediate CD43 levels in bone marrow 
from HDAC7-deficient mice (see Fig. S1 for gating strategy). 
A similar CD43 expression pattern was observed when the 
CD19 marker was included in the analysis (Fig. S1). Further-
more, an alternative staining strategy including CD25 as a 
marker corroborated that the absence of HDAC7 results in 
a block in B cell development at the pro–B to pre–B cell 
transition (Fig. S1). These findings collectively indicate that 
HDAC7 is necessary for early B cell development.
Next, we assessed the impact of HDAC7 deficiency in 
peripheral organs. We found that HDAC7 knockout mice 
had many fewer B cells in the spleen and blood than did 
control mice (Fig. 1 D). To assess the effect of HDAC7 de-
ficiency at later B cell developmental stages, we next ana-
lyzed B cell maturation in the spleen of Hdac7fl/− mice and 
their littermate controls Hdac7+/−. In particular, the analysis 
of immature B cells, marginal zone B cells, follicular B cells, 
and transitional B cells revealed that the absolute numbers 
of all B cell subtypes analyzed were significantly lower in 
HDAC7-deficient mice (Fig. 1 D, and see Fig. S2 for gating 
strategy). Hematoxylin and eosin staining revealed that the 
spleens of control mice had a normal structure with well-de-
fined follicles represented by white pulp (hematoxylin stain-
ing in purple; Fig. 1 E) surrounded by red pulp (eosin staining 
in pink; Fig. 1 E). We observed that spleens from HDAC7-de-
ficient mice had a highly abnormal and unstructured mor-
phology, with smaller and poorly defined follicles (Fig. 1 E). 
We examined whether the proportions of macrophages and 
T cells were altered in the spleens of HDAC7 knockout mice. 
We found significantly higher proportions of Mac-1–positive 
cells in the spleens of HDAC7 mutant mice (Fig. 1 F). In ad-
dition, flow cytometry analysis revealed a higher percentage 
of T lymphocytes in HDAC7 knockout mice (Fig. 1 G). The 
data presented so far demonstrate that HDAC7 is essential for 
proper B lymphocyte development and its absence is associ-
ated with severe lymphopenia in the periphery and a higher 
density of macrophages and T cells in the spleen.
To get an insight into the mechanisms underlying the 
B lymphocyte developmental block observed, we first de-
termined whether the absence of HDAC7 affected cell pro-
liferation. Cell cycle analysis revealed that proliferation was 
not sensibly altered in either pro–B or pre–B cell subsets in 
the absence of HDAC7 (Fig. 2 A). Likewise, we did not ob-
serve differences in the expression of Il7r in pro–B or pre–B 
cells from wild-type and HDAC7-deficient mice, thus rein-
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forcing the finding that the proliferation status is intact in 
HDAC7-deficient B cells (Fig. 2 B). Therefore, we wondered 
whether the developmental block at the pro–B to pre–B cell 
transition in mice lacking HDAC7 might be associated with 
cell death. HDAC7-deficient pre–B cells showed a significant 
increase of 7-aminoactinomycin D (7AAD)+ cells compared 
with wild-type pre–B cells (Fig.  2  C). We also observed a 
trend to an increased cell death rate in HDAC7-deficient 
pro–B cells. Next, to test whether HDAC7 is required for 
V(D)J recombination in pro–B and pre–B cells, we exam-
ined the expression of intracellular IgHµ protein. We found 
that HDAC7-deficient pro–B and pre–B cells express IgHµ 
(although to a significantly lesser extent than control cells; 
Fig. 2 D), indicating that HDAC7 is not absolutely required 
for V(D)J recombination. Western blot experiments revealed 
that the Cre-Loxp system used in our study was highly effi-
cient because HDAC7 was completely absent in B cells from 
bone marrow of knockout mice (Fig. 3 G). Therefore, V(D)J 
rearrangements in pro–B and pre–B cells from our knockout 
mouse model are not likely caused by the presence of residual 
HDAC7. Together, these data indicate that pro–B and pre–B 
cells lacking HDAC7 undergo V(D)J recombination but are 
more susceptible to apoptosis, which may explain the severely 
reduced numbers of pre–B and subsequent B cell subsets in the 
bone marrow and the periphery of HDAC7-deficient mice.
Because HDAC7 is a bona fide transcriptional repres-
sor, we wondered whether HDAC7 is involved in silencing 
lineage-inappropriate genes, thereby ensuring the correct 
acquisition of B cell identity. To address this possibility, we 
performed global gene expression profiling in pro–B cells 
purified from Hdac7fl/− mice and their Hdac7+/− littermate 
control mice. Microarray analysis showed that 1,750 and 
1,424 genes were up-regulated and down-regulated, respec-
tively, in HDAC7-deficient pro–B cells (Dataset S1). To gain 
functional insights into the genes that were up-regulated in 
the absence of HDAC7, we performed gene set enrichment 
analysis based on the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathways and the gene ontology (GO) 
categories corresponding to Biological Processes (Fig. 3 A). 
The KEGG pathway analysis showed that the up-regulated 
genes were enriched in MAPK signaling, T cell receptor 
signaling, lysozyme, ubiquitin-mediated proteolysis, endo-
Figure 1. HdAc7 is required for early B cell development. (A) Absolute numbers of total bone marrow cells (Hdac7fl/− [n = 6] and Hdac7+/− [n = 8]) 
and total spleen cells (Hdac7+/− [n = 12] and Hdac7fl/− [n = 9]). (B) Representative photograph of the spleen from Hdac7+/− and Hdac7fl/− mice. (C) Abso-
lute numbers of bone marrow B220+ B cells (Hdac7fl/− [n = 5] and Hdac7+/− [n = 8]), B220+CD43+IgM− pro–B cells (Hdac7fl/− [n = 5] and Hdac7+/− [n = 8]), 
B220+CD43−IgM− pre–B cells (Hdac7fl/− [n = 6] and Hdac7+/− [n = 6]), B220+IgM+ immature B cells (Hdac7fl/− [n = 7] and Hdac7+/− [n = 9]), and B220+IgM+ 
IgD+ mature recirculating B cells (Hdac7fl/− [n = 7] and Hdac7+/− [n = 9]). (D) Graph on the left shows the absolute numbers of B220+ B cells from spleen 
of Hdac7+/− (n = 12) and Hdac7fl/− (n = 9) mice. Graph in the middle shows the percentage of B220+ cells in the blood from Hdac7+/− (n = 4) and Hdac7fl/− 
(n = 4) mice. Graph on the right shows absolute numbers of spleen B cell subsets from wild-type and HDAC7-deficient mice: B220+IgM+IgD+ mature B cells 
(Hdac7+/− [n = 7] and Hdac7fl/− [n = 5]), CD21brightCD23+ marginal zone (MZ) B cells (Hdac7+/− [n = 12] and Hdac7fl/− [n = 9]), and CD21+CD23brightCD93− fol-
licular (FO; Hdac7+/− [n = 9] and Hdac7fl/− [n = 7]) and CD21+CD23brightCD93+ transitional (T; Hdac7+/− [n = 8] and Hdac7fl/− [n = 7]) B cells. (E) Hematoxylin 
and eosin staining of the spleen from Hdac7+/− and Hdac7fl/− mice. (F) Percentages of granulocytes and macrophages from the spleen of Hdac7+/− (n = 9) and 
Hdac7fl/− (n = 7) mice. Mean values are shown as horizontal bars. ns, not significant. (G) Representative FACS analyses from three independent experiments 
are shown on T lymphocytes from the spleens of Hdac7+/− and Hdac7fl/− mice. FSC, forward scatter. Data are represented as the mean ± SEM. Statistical 
significances were identified using the unpaired two-tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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cytosis, chemokine signaling, and Fc-γ–mediated phagocy-
tosis pathways (Fig.  3  A). The Biological Processes analysis 
revealed that the up-regulated genes belong to the catego-
ries representing transcription, chromatin organization and 
modification, hemopoiesis, leukocyte activation, intracellular 
signaling cascade, immune system development, endocytosis, 
T cell activation and differentiation, and myeloid activation 
processes (Fig. 3 A). Strikingly, we observed that the absence 
of HDAC7 from pro–B cells was associated with the up-reg-
ulation of key genes for myeloid cell functions, such as Itgam, 
Itgax, Ifi204, Ccl3, Ccl4, and Ccr2, among others (Table S1). 
Indeed, HDAC7 deficiency prompted the expression of the 
key macrophage marker Mac-1 (encoded by Itgam) in gated 
bone marrow lymphocytes or purified CD19+ B cells (Fig. 3, 
B and C). In addition, loss of HDAC7 from pro–B cells led 
to the up-regulation of many transcription factors, several of 
which play a role in myeloid cell differentiation (Fosb, Egr1, 
Crebzf, Cebpb, and Cebpd; Table S1). Strikingly, analysis of 
data from the Immunological Genome Project to compare 
the expression pattern between HDAC7 and selected myeloid 
genes in purified B cells and macrophage populations revealed 
an inverse correlation with gene expression (Fig.  3 D). We 
also found that HDAC7 deficiency led to the up-regulation 
of T cell genes, such as Cd28, Cd69, Il17, and Lck, and the 
T cell transcription factors Runx1, Runx3, and Nfat5 (Table 
S1). Changes in the expression of selected genes (Itgam, Ccl3, 
Cd28, and Cd69) were validated by quantitative RT-PCR 
(Fig. 3 E). Interestingly, analysis of the down-regulated genes 
in the absence of HDAC7 did not reveal any enrichment in 
either gene ontology or KEGG pathways related to biological 
aspects of B lymphocytes (not depicted). Of note, our mi-
croarray experiments did not reveal any changes either in the 
expression of key B cell transcription factors such as PAX5, 
E2A, and EBF or in other important B lymphocyte genes 
(CD19 and RAG2). The expression of Cd19, Pax5, and Rag2 
was determined by quantitative RT-PCR (Fig. 3 F). PAX5 
and EBF protein levels were determined by Western blot as-
says (Fig. 3 G). The fact that HDAC7 deficiency imposes a 
strong block on B cell development, even in the presence of B 
cell master regulators, indicates that it is a potent regulator of 
Figure 2. HdAc7 deficiency results in 
increased cell death in pro–B and pre–B 
cells. (A) Representative Hoechst staining 
of pro–B and pre–B cells from Hdac7+/− and 
Hdac7fl/− mice form three independent ex-
periments. Bars represent the percentage of 
cycling cells. (B) RT–quantitative PCR exper-
iments for gene expression of Il7r in pro–B 
cells from Hdac7+/− and Hdac7fl/− mice. (C) In-
creased cell death of pro–B and pre–B cells in 
the absence of HDAC7. Bar graph depicts the 
percentage of apoptotic-dead (7AAD+) cells. 
(D) Representative histogram staining show-
ing the expression of intracellular IgHµ (Igm 
IC) in pro–B and pre–B cells from Hdac7+/− and 
Hdac7fl/− mice. Bar graph depicts the cell count 
expressing IgHµ. All data are represented as 
the mean ± SEM of three independent experi-
ments. Statistical significances were identified 
using the unpaired two-tailed Student’s t test. 
*, P < 0.05; ***, P < 0.001.
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B cell lymphopoiesis. Collectively, these findings demonstrate 
that HDAC7 acts as a transcriptional repressor of lineage-in-
appropriate genes in B cell progenitors.
Because we previously showed that HDAC7 specifically 
interacts with the transcription factor MEF2C but not with 
other B cell–specific transcription factors in B cell precur-
sors (Barneda-Zahonero et al., 2013), we examined whether 
HDAC7 is recruited to MEF2 binding sites located at the 
promoter of nonlymphoid genes in pro–B cells, leading to 
their transcriptional silencing, by performing chromatin 
immunoprecipitation (ChIP) experiments. First, using the 
TFconsite bioinformatic tool, we found that promoters of 
Itgam, Cd69, Cd28, and Ccl3 contain putative MEF2 bind-
ing sites. Chromatin prepared from bone marrow wild-type 
B cells was subjected to ChIP assays with an antibody spe-
cific to HDAC7. Quantitative PCR analysis of the immu-
noprecipitated material with specific primers for the Itgam, 
Ccl3, Cd28, and Cd69 promoters indicated that HDAC7 
was enriched at their putative binding sites in these loci in 
pro–B cells (Fig. 4 A). Interestingly, we did not observe an 
Figure 3. Pro–B cells from HdAc7-deficient mice express genes from alternative lineages. (A) KEGG pathway enrichment and Gene Ontology (GO) 
analysis of up-regulated genes in HDAC7-deficient pro–B cells. (B) Representative FACS analyses from three independent experiments showing Mac-1 
expression in gated bone marrow lymphocytes from Hdac7+/− and Hdac7fl/− mice (top). Histogram showing Mac-1 expression in gated bone marrow 
lymphocytes from Hdac7+/− (red) and Hdac7fl/− (blue) mice (bottom). FSC, forward scatter. (C) Representative FACS analyses from three independent 
experiments showing Mac-1 expression in purified CD19+ bone marrow lymphocytes from Hdac7+/− and Hdac7fl/− mice. (D) Heatmap showing the expression 
pattern of HDAC7 and selected myeloid genes in different hematopoietic cell subsets. Data were obtained from the Immunological Genome Project. A 
description of the different cell subsets analyzed can be found at www .Immgen .org. (E) RT–quantitative PCR experiments for gene expression changes for 
selected up-regulated genes in the absence of HDAC7. *, P < 0.05; **, P < 0.01. (F) RT–quantitative PCR experiments for gene expression levels of B cell 
genes. (E and F) Data are represented as the mean ± SEM of three independent experiments. (G) Western blot analysis for the expression of HDAC7 and B 
cell transcription factors in wild-type and HDAC7-deficient B lymphocytes.
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enrichment of HDAC7 at the Pax5 promoter (Fig. 4 A). We 
also found that MEF2C was enriched at the promoters of 
HDAC7 target genes (Fig.  4  A). To definitively prove that 
HDAC7 represses its target genes through interaction with 
MEF2C, we performed a rescue or gain of function exper-
imental approach. We transduced purified B cells from the 
bone marrow and spleens of wild-type and HDAC7-deficient 
mice with retroviral vectors for either normal HDAC7 or a 
mutant form carrying a deletion of the entire 17–amino acid 
stretch that mediates the interaction with MEF2 transcription 
factors (MIG-HDAC7-ΔMEF; Dequiedt et al., 2003), fused 
to GFP, and GFP-positive cells were sorted. We tested the 
HDAC7 mutant for its ability to repress Itgam and Cd69 in 
bone marrow B cells lacking HDAC7. As experimental con-
trols, we transduced wild-type and HDAC7-deficient cells 
with empty retroviral vector (MIG). Expression of wild-type 
HDAC7 in knockout cells resulted in a significant decrease in 
the expression of Itgam and Cd69 mRNA levels (Fig. 4 B), 
whereas expression of the HDAC7 mutant defective for 
MEF2C binding had no significant effect. We also observed 
that the expression of wild-type, but not mutant, HDAC7 
reduced the expression of Mac-1 protein in purified B cells in 
the spleens of knockout mice (Fig. 4 C). These experiments 
demonstrate that the HDAC7–MEF2C interaction is neces-
sary for HDAC7 to repress its target genes.
Next, we analyzed the enrichment of active and re-
pressive histone marks at HDAC7 target genes in the ab-
sence or presence of HDAC7. Interestingly, we observed that 
H3Ac(K9/K14) and H4K16Ac were already present at the 
promoters of HDAC7 target genes in wild-type B cells. The 
absence of HDAC7 from B cells was associated with a mod-
erate but significant increase of both histone marks and a de-
crease of the repressive mark H3K27me3 in the promoters 
of its target genes (Fig. 4 D). To test whether, in addition to 
target promoters, H3Ac(K9/14) are also enriched at other 
genomic regions, we performed ChIP-seq assays using puri-
fied pro–B cells from wild-type and HDAC7-deficient mice. 
Both histone marks were also found at other genomic loca-
tions such as introns, exons, and intergenic regions (Fig. 5 A 
and Dataset S2). Interestingly, many of the genes up-regulated 
in HDAC7-deficient pro–B cells showed an enrichment in 
H3Ac(K9/K14) in wild-type and HDAC7-deficient pro–B 
cells (Dataset S3). At the global level, only slight changes in 
enrichment of H3Ac(K9/K14) were detectable in the ab-
sence of HDAC7 (Fig. 5 B). However, individual analysis by 
ChIP coupled with quantitative PCR confirmed the signifi-
cance of such changes observed for HDAC7-deficient pro–B 
cells (Fig.  4  D). Karmodiya et al. (2012) recently reported 
that H3K9Ac and H3K14Ac marks not only associate with 
promoters of actively transcribed genes, but also with devel-
opmentally regulated bivalent promoters, as well as with en-
hancers in mouse embryonic stem cells. Similarly, pro–B cells 
in the bone marrow are largely undifferentiated lymphocyte 
progenitors, and the presence of histone active marks may in-
dicate that genes from alternative lineages are poised, resulting 
in a certain degree of cell plasticity toward other hematopoi-
etic cell types. In fact, genetic ablation of key B cell factors 
such as PAX5, E2A, and EBF1 in mice results in the inappro-
priate expression of genes from other cell types within the 
hematopoietic system. Accordingly, here we demonstrate that 
HDAC7 deficiency from pro–B cells leads to expression of 
myeloid and T cell genes. Recently, van Oevelen et al. (2015) 
determined the presence of enhancers at macrophage genes in 
pre–B cells. The authors showed that during trans-differentia-
tion of pre–B cells into macrophages by exogenous expression 
of the myeloid transcription factor C/EBP-α, this transcrip-
tion factor binds to two types of myeloid enhancers in B cells: 
preexisting enhancers that are bound by PU.1, providing a 
platform for incoming C/EBP-α; and de novo enhancers 
that are targeted by C/EBP-α (van Oevelen et al., 2015). This 
prompted us to analyze whether these macrophage gene en-
hancers were also enriched in H3K9/K14Ac in our ChIP-
seq experiment. Interestingly, preexisting enhancers that are 
bound by PU.1 were indeed occupied by both histone marks 
in wild-type and HDAC7-deficient pro–B cells (Fig. 5 B and 
Dataset S4). This finding further supports the notion that lin-
eage-inappropriate genes may be epigenetically poised in B 
cell progenitors. To test the possibility that HDAC7 could be 
also recruited at enhancers of its target genes, we performed 
ChIP experiments. Strikingly, we found that HDAC7 is also 
bound to enhancers of Itgam and Cd69 (Fig. 5 C), in addi-
tion to their promoters. The absence of HDAC7 from pro–B 
cells was associated with a significant enrichment of the acti-
vating histone marks, H3Ac(K9/K14) and H4K16Ac, in the 
enhancers of its target genes. Interestingly, enrichment of the 
enhancer mark H3K27Ac was also increased in the same en-
hancer loci in HDAC7-deficient pro–B cells (Fig. 5 D). Col-
lectively, our results demonstrate that HDAC7 is recruited to 
the promoters and enhancers of lineage-inappropriate genes 
in pro–B cells, resulting in their transcriptional silencing. The 
finding that HDAC7 is also recruited at enhancers of its target 
genes represents a novel mechanism by which this HDAC 
may control gene expression in B lymphocytes.
Our results represent the first evidence that HDAC7 acts 
in vivo as a master regulator of B cell identity and develop-
ment. We demonstrate that HDAC7 is an essential transcrip-
tional repressor of genes from alternative lineages that ensures 
proper B cell development. The fact that B cell transcription 
factors, such as E2A and PAX5, may induce the expression 
of HDAC7 in pro–B cells indicates the potential existence of 
an alternative mechanism involved in gene repression. B cell 
transcription factors not only recruit corepressors to silence 
their lineage-inappropriate target genes, but also may act 
through an indirect mechanism that induces the expression 
of a transcriptional repressor, such as HDAC7, which, in turn, 
through the interaction with MEF2C, directly represses genes 
from alternative lineages. In conclusion, we have identified 
HDAC7 as a lymphoid-specific and bona fide transcriptional 
repressor that is essential for proper B lymphocyte develop-
ment and for ensuring the acquisition of the correct gene 
o
n
 M
arch 6, 2017
D
ow
nloaded from
 
Published October 17, 2016
2597JEM Vol. 213, No. 12
Figure 4. HdAc7 and MEF2c are recruited to the promoters of lineage-inappropriate genes in bone marrow B lymphocytes. (A) ChIP experi-
ments showing the enrichment of HDAC7 and MEF2C to putative MEF2 binding sites on the Itgam, Ccl3, Cd28, Cd69, and Pax5 gene loci in bone marrow 
CD19+ B cells. Results are presented as the relative enrichment over input and are based on the results of three independent experiments. (B and C) 
Purified HDAC7-deficient B cells from bone marrow (B) and spleen (C) were infected with MSCV-GFP, MSCV-GFP-HDAC7, and MSCV-GFP-HDAC7(ΔMEF) 
viruses. As an experimental control, wild-type B cells were transduced with MSCV-GFP. (B) GFP+ cells were sorted and mRNA extracted. RT–quantitative 
PCR experiments for Itgam (left) and Cd69 (right) gene expression changes in HDAC7-deficient B cells. Data are given as mean ± SEM of values obtained 
in three independent experiments. (C) Cells were stained with a Mac-1 antibody, and the GFP-positive fractions were gated and the results plotted. (D) 
ChIP experiments showing the enrichment of H3Ac(K9/K14), H3K27me3, and H4K16Ac to the Itgam, Ccl3, Cd28, Cd69, and Pax5 gene loci in bone mar-
row CD19+ B cells from Hdac7+/− and Hdac7fl/− mice. Results are presented as the relative enrichment over input and are based on the results of three 
independent experiments. Data are given as mean ± SEM of values obtained in three independent experiments. Statistical significances were identified 
using the unpaired two-tailed Student’s t test. *, P < 0.05; **, P < 0.01.
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Figure 5. HdAc7 is recruited at enhancers of its target genes, and its deficiency results in increased enrichment of histone active marks. 
(A) Genomic distribution of H3Ac(K9/K14) enrichment in Hdac7+/− and Hdac7fl/− pro–B cells. (B) Examples for H3Ac(K9/K14) enrichment at enhancers 
and promoters of selected genes. (C) ChIP experiments showing the enrichment of HDAC7 to Itgam and Cd69 promoters and enhancers in pro–B cells 
from Hdac7+/− and Hdac7fl/− mice. (D) H3Ac(K9/K14), H4K16Ac, and H3K27Ac enrichment to the Itgam, Ccl3, and Cd69 enhancers in pro–B cells from 
Hdac7+/− and Hdac7fl/− mice. Results are presented as the relative enrichment over input and are based on the results of three independent experiments. 
(C and D) Data are given as mean ± SEM of values obtained in three (C) and four (D) independent experiments. Statistical significances were identified 
using the unpaired two-tailed Student’s t test. *, P < 0.05.
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identity of B cells. Our findings represent a significant ad-
vance in our understanding of the transcriptional complexity 
underlying B cell generation.
MAtErIAls And MEtHods
Mouse and animal care
Hdac7f l/− mice were previously described (Chang et al., 2006) 
and were provided by E. Olson (University of Texas South-
western Medical Center, Dallas, TX). mb1-Creki/+ mice were 
provided by M. Reth (Max Planck Institute of Immunology 
and Epigenetics, Freiburg, Germany). Experiments were per-
formed with mice that were 4–6 wk of age. Animal housing and 
handling, and all procedures involving mice, were approved by 
the Bellvitge Biomedical Research Institute ethics committee, 
in accordance with Spanish national guidelines and regulations.
Flow cytometry and cell-sorting experiments
Cells were extracted from bone marrow and spleen. Isolated 
cells were incubated with Fc receptor–blocking antibody 
(BD) for 10 min at 4°C to reduce nonspecific staining. Cells 
were then stained with anti-B220 (PerCP-Cy5.5), anti-CD43 
(APC), anti-IgM (FITC), anti-CD25 (APC), anti-IgD (PE), 
anti-Gr1 (PE), anti-CD11b (APC), anti-CD21 (FITC), an-
ti-CD23 (PE), anti-CD93 (APC), and anti-CD3 (FITC; BD) 
for 30 min at 4°C in the dark. For intracellular IgHµ staining, 
cells were first stained with surface markers, permeabilized and 
fixed with buffer Perm/Wash (BD), and stained with anti-IgM 
mu-biotin antibody (Jackson ImmunoResearch Laboratories, 
Inc.) followed by incubation with streptavidin-PE. Cells were 
processed in a Gallios flow cytometer (Beckman Coulter), and 
the data were analyzed using FlowJo software (Tree Star). For 
cell-sorting experiments, bone marrow cells were incubated 
with Fc receptor–binding antibody and then stained with 
anti-B220 (PerCP-Cy5.5), anti-CD43 (APC), and anti-IgM 
(FITC; BD), under the same conditions. B220+CD43+IgM− 
cells were isolated on a MoFlo sorter (Beckman Coulter).
retroviral supernatant generation and cellular transduction
For retrovirus generation, the MSCV-GFP, MSCV-GFP-
HDAC7, and MSCV-GFP-HDAC7(ΔMEF) plasmids were 
transfected into the packaged cell line Platinum-E, and super-
natants were collected at 48–72 h after transfection. Purified 
B cells were spin infected, and 48 h later, GFP+ cells were 
either sorted or analyzed by flow cytometry.
spleen section histology
Spleens from Hdac7f l/− mice and Hdac7+/− control mice were 
fixed in 4% formaldehyde, embedded in paraffin, sectioned at 
4 µm, and stained with hematoxylin and eosin. Samples were 
imaged under a Scope.A1 microscope (ZEI SS).
Western blot
Western blot analysis was performed according to standard 
procedures. Western blots were developed with the Enhanced 
Chemiluminescence detection kit (GE Healthcare).
Proliferation and cell cycle assays
Cell proliferation and cell death were assessed by Hoechst 
and 7AAD staining, respectively. Cells were analyzed by flow 
cytometry using a Gallios flow cytometer.
Microarray experiments
Total RNA from sorted pro–B cells of Hdac7+/− and 
Hdac7f l/− mice was extracted by TRIzol and then puri-
fied. PCR-amplified RNAs were hybridized against mouse 
array chips (Mouse Genome 430 p.m. strip; Affymetrix) at 
the Institute for Research in Biomedicine Genomics Facility 
(Barcelona, Spain). Microarray analysis (GEO accession no. 
GSE66163) was performed as previously described (Barne-
da-Zahonero et al., 2013).
rt–quantitative Pcr assays
Pro–B cells were purified by cell sorting. RNA was extracted 
by TRIzol extraction (QIA GEN), and cDNA was synthe-
sized using the High Capacity cDNA Reverse Transcription 
kit (Applied Biosystems). RT–quantitative PCR was per-
formed in triplicate using SYBR Green I Master (Roche). 
PCR reactions were run and analyzed using the LightCycler 
480 Detection System (Roche). 
chIP assays
For ChIP assays, purified CD19+ B or pro–B cells from the 
bone marrow of Hdac7+/− and Hdac7f l/− mice were cross-
linked with 1% formaldehyde and subjected to immunopre-
cipitation after sonication. ChIP experiments were performed 
using the LowCell# ChIP kit (Diagenode) according to the 
manufacturer’s instructions. The following antibodies were 
used: anti-HDAC7 (Abcam), anti-MEF2C (Cell Signaling 
Technology), anti-H3Ac(K9/K14) (EMD Millipore), an-
ti-H4K16Ac (Active Motif), anti-H3K27me3 (EMD Milli-
pore), and anti-H3K27Ac (Abcam). Analyses were performed 
by real-time quantitative PCR. Data are represented as the 
ratio between the bound fraction of the HDAC7, MEF2C, and 
histone modification antibody relative to the input control.
chIP-seq experiments
Sorted pro–B cells from the bone marrow of wild-type and 
Hdac7-deficient mice were cross-linked with 1% formal-
dehyde and sonicated using an S220 Focused ultrasonicator 
(Covaris). An anti-H3Ac(K9/K14) antibody (EMD Milli-
pore) was used to perform ChIP from 100,000 pro–B cells 
using the True MicroChIP kit (Diagenode) according to the 
manufacturer’s instructions. ChIP library construction and se-
quencing were performed according to standard procedures 
at the Centre for Genomic Regulation Genomics Core Fa-
cility (Barcelona, Spain). The quality of raw reads was checked 
using FastQC, and adapters were trimmed with a Skewer 
trimming tool (Bioinformatics) before mapping. Trimmed 
reads were mapped against the mouse genome (Mus muscu-
lus, genome version mm9) with Burrows-Wheeler Aligner–
MEM, and duplicates were removed with the MarkDuplicates 
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tool in the Picard software. Data analysis, involving peak 
calling and annotation, was performed by qGenomics Lab-
oratories using the Hypergeometric Optimization of Motif 
EnRichment v.4.8 suite. Variable-width peaks were called in 
the immunoprecipitated sample, using the input sample as 
a control, with the findPeaks function in the histone mode 
and a false discovery rate set to 0.001. Peaks were annotated 
using the annotatePeaks (Integrative Genomics) tool (SRA 
accession no. SRP076788).
statistics
Statistical significance was determined by the two-tailed un-
paired Student’s t test.
online supplemental material
Figs. S1 and S2 show the gating strategy used in the phe-
notypic characterization of wild-type and HDAC7-deficient 
mice. Table S1 shows a selection of up-regulated genes in 
HDAC7-deficient pro–B cells. Dataset S1 shows the list of 
genes up-regulated and down-regulated in HDAC7-defi-
cient pro–B cells. Datasets S2, S3, and S4 show the ChIP-
seq analysis of H3Ac(K9/K14) enrichment in wild-type and 
HDAC7-deficient pro–B cells (genomic distribution, anno-
tated peaks, and enrichment at macrophage gene enhancers).
AcknoWlEdgMEnts
We thank Dr. Eric Olson and Dr. Michael Reth for providing the Hdac7loxp/− and mb1-
Cre mice, respectively. We also thank Dr. Pura Muñoz Cánoves and Dr. Thomas Graf 
for helpful comments on the manuscript.
This work was supported by grants from the Spanish Ministry of Economy and 
Competitiveness (SAF2011-28290 and SAF2014-58228-R).
The authors declare no competing financial interests.
Submitted: 14 May 2015
Accepted: 14 September 2016
rEFErEncEs
Bain, G., E.C. Robanus Maandag, H.P. te Riele, A.J. Feeney, A. Sheehy, M. 
Schlissel, S.A. Shinton, R.R. Hardy, and C. Murre. 1997. Both E12 and 
E47 allow commitment to the B cell lineage. Immunity. 6:145–154. http 
://dx .doi .org /10 .1016 /S1074 -7613(00)80421 -5
Barneda-Zahonero, B., L. Roman-Gonzalez, O. Collazo, T. Mahmoudi, and 
M. Parra. 2012. Epigenetic regulation of B lymphocyte differentiation, 
transdifferentiation, and reprogramming. Comp. Funct. Genomics. 2012. 
http ://dx .doi .org /10 .1155 /2012 /564381
Barneda-Zahonero, B., L. Román-González, O. Collazo, H. Rafati, A.B. Islam, 
L.H. Bussmann, A. di Tullio, L. De Andres, T. Graf, N. López-Bigas, et al. 
2013. HDAC7 is a repressor of myeloid genes whose downregulation is 
required for transdifferentiation of pre–B cells into macrophages. PLoS 
Genet. 9:e1003503. http ://dx .doi .org /10 .1371 /journal .pgen .1003503
Chang, S., B.D. Young, S. Li, X. Qi, J.A. Richardson, and E.N. Olson. 2006. 
Histone deacetylase 7 maintains vascular integrity by repressing matrix 
metalloproteinase 10. Cell. 126:321–334. http ://dx .doi .org /10 .1016 /j 
.cell .2006 .05 .040
Cobaleda, C., and M. Busslinger. 2008. Developmental plasticity of 
lymphocytes. Curr. Opin. Immunol. 20:139–148. http ://dx .doi .org /10 
.1016 /j .coi .2008 .03 .017
Delogu, A., A. Schebesta, Q. Sun, K. Aschenbrenner, T. Perlot, and M. 
Busslinger. 2006. Gene repression by Pax5 in B cells is essential for blood 
cell homeostasis and is reversed in plasma cells. Immunity. 24:269–281. 
http ://dx .doi .org /10 .1016 /j .immuni .2006 .01 .012
Dengler, H.S., G.V. Baracho, S.A. Omori, S. Bruckner, K.C. Arden, D.H. 
Castrillon, R.A. DePinho, and R.C. Rickert. 2008. Distinct functions for 
the transcription factor Foxo1 at various stages of B cell differentiation. 
Nat. Immunol. 9:1388–1398. http ://dx .doi .org /10 .1038 /ni .1667
Dequiedt, F., H. Kasler, W. Fischle, V. Kiermer, M. Weinstein, B.G. Herndier, and 
E. Verdin. 2003. HDAC7, a thymus-specific class II histone deacetylase, 
regulates Nur77 transcription and TCR-mediated apoptosis. Immunity. 
18:687–698. http ://dx .doi .org /10 .1016 /S1074 -7613(03)00109 -2
Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P.J. Nielsen, R. Pelanda, and 
M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-
cre mice. Proc. Natl. Acad. Sci. USA. 103:13789–13794. http ://dx .doi .org 
/10 .1073 /pnas .0605944103
Ikawa, T., H. Kawamoto, L.Y. Wright, and C. Murre. 2004. Long-term cultured 
E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity. 
20:349–360. http ://dx .doi .org /10 .1016 /S1074 -7613(04)00049 -4
Karmodiya, K., A.R. Krebs, M. Oulad-Abdelghani, H. Kimura, and L. Tora. 
2012. H3K9 and H3K14 acetylation co-occur at many gene regulatory 
elements, while H3K14ac marks a subset of inactive inducible promoters 
in mouse embryonic stem cells. BMC Genomics. 13. http ://dx .doi .org 
/10 .1186 /1471 -2164 -13 -424
Kondo, M., I.L. Weissman, and K. Akashi. 1997. Identification of clonogenic 
common lymphoid progenitors in mouse bone marrow. Cell. 91:661–
672. http ://dx .doi .org /10 .1016 /S0092 -8674(00)80453 -5
Kong, N.R., M. Davis, L. Chai, A. Winoto, and R. Tjian. 2016. MEF2C and 
EBF1 co-regulate B cell-specific transcription. PLoS Genet. 12:e1005845. 
http ://dx .doi .org /10 .1371 /journal .pgen .1005845
Lin, H., and R. Grosschedl. 1995. Failure of B-cell differentiation in mice 
lacking the transcription factor EBF. Nature. 376:263–267. http ://dx .doi 
.org /10 .1038 /376263a0
Lin, Y.C., S. Jhunjhunwala, C. Benner, S. Heinz, E. Welinder, R. Mansson, M. 
Sigvardsson, J. Hagman, C.A. Espinoza, J. Dutkowski, et al. 2010. A global 
network of transcription factors, involving E2A, EBF1 and Foxo1, that 
orchestrates B cell fate. Nat. Immunol. 11:635–643. http ://dx .doi .org /10 
.1038 /ni .1891
Lukin, K., S. Fields, L. Guerrettaz, D. Straign, V. Rodriguez, S. Zandi, R. 
Månsson, J.C. Cambier, M. Sigvardsson, and J. Hagman. 2011. A dose-
dependent role for EBF1 in repressing non-B-cell-specific genes. Eur. J. 
Immunol. 41:1787–1793. http ://dx .doi .org /10 .1002 /eji .201041137
Nechanitzky, R., D. Akbas, S. Scherer, I. Györy, T. Hoyler, S. Ramamoorthy, 
A. Diefenbach, and R. Grosschedl. 2013. Transcription factor EBF1 
is essential for the maintenance of B cell identity and prevention of 
alternative fates in committed cells. Nat. Immunol. 14:867–875. http ://
dx .doi .org /10 .1038 /ni .2641
Parra, M. 2009. Epigenetic events during B lymphocyte development. 
Epigenetics. 4:462–468. http ://dx .doi .org /10 .4161 /epi .4 .7 .10052
Parra, M. 2015. Class IIa HDACs - new insights into their functions in 
physiology and pathology. FEBS J. 282:1736–1744. PubMedhttp ://dx 
.doi .org /10 .1111 /febs .13061
Parra, M., and E. Verdin. 2010. Regulatory signal transduction pathways for 
class IIa histone deacetylases. Curr. Opin. Pharmacol. 10:454–460. http ://
dx .doi .org /10 .1016 /j .coph .2010 .04 .004
Pongubala, J.M., D.L. Northrup, D.W. Lancki, K.L. Medina, T. Treiber, E. 
Bertolino, M. Thomas, R. Grosschedl, D. Allman, and H. Singh. 2008. 
Transcription factor EBF restricts alternative lineage options and 
promotes B cell fate commitment independently of Pax5. Nat. Immunol. 
9:203–215. http ://dx .doi .org /10 .1038 /ni1555
Pridans, C., M.L. Holmes, M. Polli, J.M. Wettenhall, A. Dakic, L.M. Corcoran, 
G.K. Smyth, and S.L. Nutt. 2008. Identification of Pax5 target genes 
o
n
 M
arch 6, 2017
D
ow
nloaded from
 
Published October 17, 2016
2601JEM Vol. 213, No. 12
in early B cell differentiation. J. Immunol. 180:1719–1728. http ://dx .doi 
.org /10 .4049 /jimmunol .180 .3 .1719
Revilla-i-Domingo, R., I. Bilic, B. Vilagos, H. Tagoh, A. Ebert, I.M. Tamir, L. 
Smeenk, J. Trupke, A. Sommer, M. Jaritz, and M. Busslinger. 2012. The 
B-cell identity factor Pax5 regulates distinct transcriptional programmes 
in early and late B lymphopoiesis. EMBO J. 31:3130–3146. http ://dx 
.doi .org /10 .1038 /emboj .2012 .155
Schwickert, T.A., H. Tagoh, S. Gültekin, A. Dakic, E. Axelsson, M. Minnich, 
A. Ebert, B. Werner, M. Roth, L. Cimmino, et al. 2014. Stage-specific 
control of early B cell development by the transcription factor Ikaros. 
Nat. Immunol. 15:283–293. http ://dx .doi .org /10 .1038 /ni .2828
Stehling-Sun, S., J. Dade, S.L. Nutt, R.P. DeKoter, and F.D. Camargo. 2009. 
Regulation of lymphoid versus myeloid fate ‘choice’ by the transcription 
factor Mef2c. Nat. Immunol. 10:289–296. http ://dx .doi .org /10 .1038 /ni 
.1694
Urbánek, P., Z.Q. Wang, I. Fetka, E.F. Wagner, and M. Busslinger. 1994. 
Complete block of early B cell differentiation and altered patterning of 
the posterior midbrain in mice lacking Pax5/BSAP. Cell. 79:901–912. 
http ://dx .doi .org /10 .1016 /0092 -8674(94)90079 -5
van Oevelen, C., S. Collombet, G. Vicent, M. Hoogenkamp, C. Lepoivre, A. 
Badeaux, L. Bussmann, J.L. Sardina, D. Thieffry, M. Beato, et al. 2015. C/
EBPα activates pre-existing and de novo macrophage enhancers during 
induced pre–B cell transdifferentiation and myelopoiesis. Stem Cell Rep. 
5:232–247. http ://dx .doi .org /10 .1016 /j .stemcr .2015 .06 .007
Whyte, W.A., D.A. Orlando, D. Hnisz, B.J. Abraham, C.Y. Lin, M.H. Kagey, 
P.B. Rahl, T.I. Lee, and R.A. Young. 2013. Master transcription factors 
and mediator establish super-enhancers at key cell identity genes. Cell. 
153:307–319. http ://dx .doi .org /10 .1016 /j .cell .2013 .03 .035
Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-loop-helix gene 
E2A is required for B cell formation. Cell. 79:875–884. http ://dx .doi 
.org /10 .1016 /0092 -8674(94)90076 -0
o
n
 M
arch 6, 2017
D
ow
nloaded from
 
Published October 17, 2016
